Glaukos Corp.

GKOS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
Revenue $181.3M $159.3M $114.4M $71.7M $45.6M $20.9M
Cost of Revenue $25.1M $21.1M $16.2M $13.0M $11.4M $2.5M
Gross Profit $156.2M $138.2M $98.2M $58.7M $34.2M $18.4M
Gross Margin 86.2% 86.8% 85.9% 81.9% 75.0% 87.9%
Operating Expenses
Research & Development $49.7M $38.9M $29.2M $25.0M $19.2M $15.5M
SG&A Expense $119.5M $96.3M $64.8M $44.0M $28.1M $17.1M
Operating Income $-13.0M $-2.3M $4.2M $-10.3M $-13.2M $-14.2M
Operating Margin -7.2% -1.4% 3.7% -14.4% -28.9% -67.8%
Interest Expense
Pretax Income $-12.4M $1.0K $4.6M $-38.3M $-14.0M $-14.2M
Income Tax Expense $583.0K $93.0K $43.0K $33.0K $18.0K $6.0K
Net Income $-13.0M $-92.0K $4.5M $-37.2M $-12.1M $-12.6M
Net Margin -7.1% -0.1% 4.0% -51.9% -26.6% -60.3%
EPS (Basic) $-0.37 $0.00 $0.14 $-1.07 $-0.33 $-0.39
EPS (Diluted) $-0.37 $0.00 $0.12 $-1.07 $-0.33 $-0.39
Shares Outstanding (Basic) 35.3M 34.4M 32.9M 34.9M 36.7M
Shares Outstanding (Diluted) 35.3M 34.4M 36.5M 34.9M 36.7M
Dividends Per Share
← Newer Page 2 of 2 Older →